A new poll reveals that while many Americans support weight-loss drugs for adults, opinions are split regarding their use among teens battling obesity.
The FDA has approved Journavx, a groundbreaking non-opioid painkiller, marking the first new class in over 20 years, aiming to eliminate the risks of opioid addiction.